Helmintic infections:
Indications for: ALBENZA
Parenchymal neurocysticercosis from active lesions due to Taenia solium (pork tapeworm). Cystic hydatid disease of the liver, lung, and peritoneum due to Echinococcus granulosus (dog tapeworm).
Adults and Children:
See full labeling. Take with meals. Neurocysticercosis: Give for 8–30 days. Hydatid: Give for 28-day cycle followed by a 14-day free interval, for a total of 3 cycles. <6yrs: not recommended. ≥6yrs (<60kg): 15mg/kg/day in 2 divided doses; max 800mg/day. ≥6yrs (≥60kg): 400mg twice daily.
ALBENZA Warnings/Precautions:
Examine for retinal lesions first. Monitor blood and hepatic function at beginning of each 28-day cycle and at least every 2 weeks; discontinue if significant increased liver enzymes or if decreases in blood counts occur. Neurocysticercosis: may need corticosteroids during the 1st week of therapy and anticonvulsants. Embryo-fetal toxicity. Advise females of reproductive potential to use effective contraception during and for 3 days after the final dose. Pregnancy: exclude status prior to initiation. Nursing mothers.
ALBENZA Classification:
Anthelmintic.
ALBENZA Interactions:
Potentiated by dexamethasone, praziquantel, cimetidine. Monitor theophylline.
Adverse Reactions:
Abnormal liver function test, abdominal pain, GI upset, headache, dizziness, increased intracranial pressure, meningeal signs, reversible alopecia, fever; rarely: leukopenia, rash, acute renal failure, hematological reactions.
How Supplied:
Tabs—2
